Document is current

Article History

Received: 8 August 2019

Revised: 13 November 2019

Accepted: 20 November 2019

First Online: 20 December 2019

Compliance with ethical standards

:

: Dr. Gliem is now employee and equity owner of F. Hoffmann-La Roche Ltd., Basel, Switzerland (since July 2019); he received financial support from Bayer AG and Heidelberg Engineering. Dr. Birtel received financial support from Heidelberg Engineering. Dr. Holz is consultant of Bayer AG, Heidelberg Engineering, and CenterVue. The Department of Ophthalmology, University Hospital of Bonn, Bonn, Germany, receives imaging devices from Heidelberg Engineering and CenterVue. Dr. Charbel Issa is consultant of Inozyme and received research support from Heidelberg Engineering. None of the authors has a proprietary interest in this study.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study protocol and study documents were approved by the local ethics committee (Ethikkommission der Medizinischen Fakultät, Rheinische Friedrich-Wilhelms-Universität Bonn; Lfd. Nr. 056/15-AMG-ff). This article does not contain any studies with animals performed by any of the authors.

: Informed consent was obtained from all individual participants included in the study.